Welters Anthony's Form 4 filing
Gilead Sciences, Inc. (GILD) · filed Aug 27, 2026
- Accession no.
- 0001213307-26-000005
- Filed
- Aug 27, 2026, 6:44 PM ET
- Trade date
- Aug 26, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.68M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Welters AnthonyCIK 0001213307 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Common Stock | MOption exerciseAcquired | +7,718 | $60.67 | +$468,251.06 | 20,612 | Direct | |
| Aug 26, 2026 | Common Stock | SSaleDisposed | −3,118 | $148.31F2 | −$462,432.45 | 17,494 | Direct | |
| Aug 26, 2026 | Common Stock | SSaleDisposed | −4,600 | $148.82F3 | −$684,590.4 | 12,894 | Direct | |
| Aug 26, 2026 | Common Stock | MOption exerciseAcquired | +10,282 | $61.35 | +$630,800.7 | 23,176 | Direct | |
| Aug 26, 2026 | Common Stock | SSaleDisposed | −3,402 | $148.24F4 | −$504,296.49 | 19,774 | Direct | |
| Aug 26, 2026 | Common Stock | SSaleDisposed | −6,880 | $148.82F5 | −$1,023,900.18 | 12,894 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Common Stock | MOption exerciseDisposed | −7,718 | $0.00 | $0 | 0 | Direct | |
| Aug 26, 2026 | Common Stock | MOption exerciseDisposed | −10,282 | $0.00 | $0 | 5,569 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Sale prices for the transactions reported range from $147.58 to $148.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Sale prices for the transactions reported range from $148.58 to $149.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Sale prices for the transactions reported range from $147.57 to $148.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Referenced by the price of 1 transaction in Table I.
- F5
Sale prices for the transactions reported range from $148.57 to $149.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Referenced by the price of 1 transaction in Table I.